Logo
Search

Rules:

Only words with 2 or more characters are accepted
Max 200 chars total
Space is used to split words, "" can be used to search for a whole string (not indexed search then)
AND, OR and NOT are prefix words, overruling the default operator
+/|/- equals AND, OR and NOT as operators.
All search words are converted to lowercase.

Search for "vitro"

Displaying results 1 to 3 out of 3

  1981 – 1989 81%
  ... of acetyl- and butyrylcholinesterase as induced by various reversible enzyme inhibitors in vitro. In: Kewitz H, Thomsen T , Bickel U, editors. Pharmacological interventions on central ... reversible inhibitors on the butyryl (EC 3.1.1.8) and acetyl (EC 3.1.1.7) cholinesterase in vitro and in vivo. Naunyn Schmiedebergs Arch Pharmakol 1988 ; Suppl. to Vol. 337:R94. Tolksdorf W, ... 1988 ; 38(12):1768-1771.. 1987 Darius H, Thomsen T , Schrör K. Cardiovascular actions in
  Size: 41 K - Created: 18-11-12 - Modified: 20-06-17 17:09
Path: /Expertise/Published Expertise/1981 – 1989

  1990 – 1999 79%
  ... bei mangelnder Chargenkonformität aus in-vitro-Freisetzungsuntersuchungen Arzneim.-Forschung/Drug ... Selective inhibition of human acetylcholinesterase in vitro by S-9977-2. Neurobiology of Aging 13, 132. 1992 . ... Thomsen T , Bachus R, Bickel U, Kewitz H. In vitro inhibition of human cholinesterases by ... 1991 . Thomsen T , Zendeh B, Fischer JP, Kewitz H. In
  Size: 61 K - Created: 18-11-12 - Modified: 20-06-17 17:09
Path: /Expertise/Published Expertise/1990 – 1999

  2010-2017 69%
  ... of print] Weiss J, Baumann S , Theile D, Haefeli WE. Desmethyl bosentan displays a similar in vitro interaction profile as bosentan. Pulm Pharmacol Ther. 2014 Dec 19. pii: ... ROTEM(®) thrombelastography parameters only at supratherapeutic anti-factor Xa levels: an in vitro study. Clin Exp Pharmacol Physiol. 2011 Nov;38(11):783-6. Feuring M, Wehling M, Schultz A . ... of print] Weiss J, Baumann S , Theile D, Haefeli WE. Desmethyl bosentan displays a similar in
  Size: 65 K - Created: 09-11-15 - Modified: 27-07-17 10:05
Path: /Expertise/Published Expertise/2010-2017

FooterEnd